• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

DMF: the Canadian MS patient experience

February 28, 2018  

ECTRIMS/EAN publish new MS treatment guidelines

January 30, 2018  

NEUROSOUND: SEQUENCING THERAPIES IN MULTIPLE SCLEROSIS

December 27, 2017  

Long-term efficacy, safety of DMTs in MS

December 20, 2017  

MS Sequencing: Part 8 – MS therapies in practice: Reader survey results

December 7, 2017  

Cladribine tablets (Mavenclad) approved in Canada for RRMS

December 4, 2017  

Cladribine tablets – Updated efficacy and safety results

November 28, 2017  

ECTRIMS 2017 SLIDE DECK

November 9, 2017  

ECTRIMS 2017 DAILY REPORT – SATURDAY EDITION

October 28, 2017  

ECTRIMS 2017 DAILY REPORT – FRIDAY EDITION

October 27, 2017  
Previous
22
23
24
25
26
Next

Browse by Topic

  • MS (414)
  • CLINICAL CASES IN MS (16)
  • EPILEPSY (36)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • DMT prescribing in Canada – survey results posted on June 6, 2025
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 2, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions